Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2026)
Elanco Animal Health (ELAN) posted Other Accumulated Expenses of $817.0 million for Q1 2026, up 10.55% sequentially from $739.0 million in Q4 2025, and up 41.84% YoY from $576.0 million in Q1 2025.
Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Other Accumulated Expenses for 10 years, with the latest figure at $817.0 million in Q1 2026.
- Quarterly Other Accumulated Expenses rose 41.84% year-over-year to $817.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $817.0 million (up 41.84% YoY) and the FY2025 annual result came in at $739.0 million, up 58.58% from the prior year.
- Other Accumulated Expenses grew to $817.0 million in Q1 2026 per ELAN's latest filing, from $739.0 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $817.0 million in Q1 2026 and troughed at $377.0 million in Q1 2023.
- A 5-year average of $551.4 million and a median of $559.0 million in 2023 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses declined 23.56% in 2022, then surged 58.58% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $454.0 million in 2022, then declined by 9.91% to $409.0 million in 2023, then climbed by 13.94% to $466.0 million in 2024, then soared by 58.58% to $739.0 million in 2025, then gained by 10.55% to $817.0 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $817.0 million, $739.0 million, and $665.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 902.00 Mn |
| Mar 31, 2026 | 817.00 Mn |
| Dec 31, 2025 | 739.00 Mn |
| Sep 30, 2025 | 665.00 Mn |
| Jun 30, 2025 | 596.00 Mn |
| Mar 31, 2025 | 576.00 Mn |
| Dec 31, 2024 | 466.00 Mn |
| Sep 30, 2024 | 685.00 Mn |
| Jun 30, 2024 | 510.00 Mn |
| Mar 31, 2024 | 574.00 Mn |
| Dec 31, 2023 | 409.00 Mn |
| Sep 30, 2023 | 574.00 Mn |
| Jun 30, 2023 | 559.00 Mn |
| Mar 31, 2023 | 377.00 Mn |
| Dec 31, 2022 | 454.00 Mn |
| Sep 30, 2022 | 435.00 Mn |
| Jun 30, 2022 | 499.00 Mn |
| Mar 31, 2022 | 438.00 Mn |
| Dec 31, 2021 | 433.00 Mn |
| Sep 30, 2021 | 390.00 Mn |